⟵ Back to Search Results

BGB-3111-306

Active, not recruiting

Study Comparing Zanubrutinib + Rituximab Versus Bendamustine + Rituximab in Participants With Untreated Mantle Cell Lymphoma

Beigene Study ID info

BGB-3111-306

ClinicalTrials.gov ID info

NCT04002297

EudraCT Number info

2019-000413-36

China Drug Trials ID info

CTR20211594

Study Overview

Sex: All

Age: 60 Years / N/A

No Study Documents

Study Overview

Sex: All

Age: 60 Years / N/A

No Study Documents